[Xanthine dehydrogenase (xanthine oxidase)].
Ichida
Kimiyoshi
K
Division of Nephrology & Hypertension, Department of Internal Medicine, Jikei University School of Medicine.
Yamaguchi
Yuichiro
Y
Matsumura
Tomohiro
T
D000493:Allopurinol / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005182:Flavin-Adenine Dinucleotide / Q000378:metabolism; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy / Q000209:etiology; D009243:NAD / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D014527:Uric Acid / Q000378:metabolism; D019820:Xanthine / Q000378:metabolism; D014968:Xanthine Dehydrogenase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D014969:Xanthine Oxidase / Q000737:chemistry / Q000378:metabolism
D004791:Enzyme Inhibitors; D005609:Free Radicals; D017382:Reactive Oxygen Species; D009243:NAD; D005182:Flavin-Adenine Dinucleotide; D019820:Xanthine; D014527:Uric Acid; D000493:Allopurinol; D014968:Xanthine Dehydrogenase; D014969:Xanthine Oxidase